Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A topical combination drug containing **selenium disulfide** (also called selenium sulfide) and **salicylic acid** is used most commonly in medicated shampoos for the treatment and management of **seborrheic dermatitis** and **dandruff**. Selenium disulfide acts as an antifungal by inhibiting the growth of Malassezia species, reducing sebum production, and functioning as a cytostatic agent to slow down abnormal cell proliferation of the epidermis. Salicylic acid is a keratolytic agent that exfoliates the stratum corneum (outermost skin layer), reducing scaling, soothing irritation, and exerting mild anti-inflammatory, antibacterial, and antifungal effects. The dual mechanism targets both the fungal and hyperkeratotic/inflammatory pathways in seborrheic dermatitis, improving symptoms such as itching, redness, dandruff, and overall scalp health[1][2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on selenium disulfide + salicylic acid.